nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Breaking the rules: decision-making under absolute resource constraints
|
Lindgren, Peter |
|
|
23 |
8 |
p. 1259-1261 |
artikel |
2 |
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
|
Husereau, Don |
|
|
23 |
8 |
p. 1309-1317 |
artikel |
3 |
Correction: Lifetime direct healthcare costs of treating colorectal cancer: a systematic review
|
Bhimani, Nazim |
|
|
23 |
8 |
p. 1413 |
artikel |
4 |
Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective
|
Zinzi, Daniela |
|
|
23 |
8 |
p. 1371-1381 |
artikel |
5 |
COVID-19 health policy evaluation: integrating health and economic perspectives with a data envelopment analysis approach
|
Klumpp, Matthias |
|
|
23 |
8 |
p. 1263-1285 |
artikel |
6 |
Does the abolition of copayment increase ambulatory care utilization?: a quasi-experimental study in Germany
|
Xu, Mingming |
|
|
23 |
8 |
p. 1319-1328 |
artikel |
7 |
Does voluntary health insurance improve health and longevity? Evidence from European OECD countries
|
Dragos, Simona Laura |
|
|
23 |
8 |
p. 1397-1411 |
artikel |
8 |
Do we care about high-cost patients? Estimating the savings on health spending by integrated care
|
Geurts, Karen |
|
|
23 |
8 |
p. 1297-1308 |
artikel |
9 |
Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data
|
Neilson, Aileen R. |
|
|
23 |
8 |
p. 1357-1369 |
artikel |
10 |
Psychometric performance of proxy-reported EQ-5D youth version 5-level (EQ-5D-Y-5L) in comparison with three-level (EQ-5D-Y-3L) in children and adolescents with scoliosis
|
Lin, Jiaer |
|
|
23 |
8 |
p. 1383-1395 |
artikel |
11 |
The impact of ambulatory care spending, continuity and processes of care on ambulatory care sensitive hospitalizations
|
Schuettig, Wiebke |
|
|
23 |
8 |
p. 1329-1340 |
artikel |
12 |
Validation of the PAM-13 instrument in the Hungarian general population 40 years old and above
|
Zrubka, Zsombor |
|
|
23 |
8 |
p. 1341-1355 |
artikel |
13 |
Value drivers of development stage biopharma companies
|
Michaeli, Daniel Tobias |
|
|
23 |
8 |
p. 1287-1296 |
artikel |